Skip to content

Application of Neuromodulation Technology Combined with Cognitive Nursing in the Treatment of Alzheimer's Disease

Application of Neuromodulation Technology Combined with Cognitive Nursing in the Treatment of Alzheimer's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016077
Enrollment
Unknown
Registered
2018-05-09
Start date
2018-05-28
Completion date
Unknown
Last updated
2018-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer’s disease

Interventions

Cognitive care 1:Cognitive care with sham tDCS
tDCS treatment group:Routine care with real tDCS
tDCS+ cognitive nursing group:Cognitive care with real tDCS
Cognitive care 2:Cognitive care with sham rTMS
rTMS treatment group:Routine care with real rTMS
rTMS+ cognitive nursing group:Cognitive care with real rTMS

Sponsors

Ningbo Kangning Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: The National Institute of Aging and the Alzheimer's Associations newly revised Diagnostic Criteria for AD (NIA-AA) in 2011 and the Vizamyl-PET age spot imaging gold standard were used as the main basis for enrollment, combining clinical and cognitive criteria (by Guardian or clinician).

Exclusion criteria

Exclusion criteria: Have had other neurological diseases (including stroke, optic myelitis, Parkinson's disease, epilepsy, etc.) and ruled out possible vascular, traumatic, medical-induced cognitive decline, unstable or severe heart, lung, liver Diseases of the kidney, hematopoietic system (including unstable angina, uncontrollable asthma, active gastric bleeding, cancer, etc.) and the presence of audiovisual impairments cannot be completed by neuropsychological tests and rating scales. The age of enrollment was 65-80 years old and the race was unanimous. There was no statistical difference between the groups. No antibiotics and alcohol abuse were used in the past month.

Design outcomes

Primary

MeasureTime frame
Mini-mental State Examination,MMSE;Alzheimer’s disease assessment scale;Wechsler Adult Intelligence Scale;Transcranial Doppler Assessment;Caregiver Burden Inventory,CBI;

Countries

China

Contacts

Public ContactHong Zheng

Ningbo Kangning Hospital

724169375@qq.com+86 0574 26302537

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026